Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)

Author(s):  Riepl Mike

Issue:  May/Jun 2019 - Volume 23, Number 3
View All Articles in Issue

Page(s):  192-199

Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 1
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 2
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 3
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 4
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 5
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 6
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 7
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 8

Download in electronic PDF format for $75

Abstract:  Polycystic ovary syndrome (Stein- Leventhal syndrome) is a common endocrinopathologic condition in reproductive- age women in the U.S. Patients with that disease are not faced with treatment choices for a single medical entity; they must manage a constellation of comorbid conditions that compromise their overall health and diminish their quality of life. The combinations of those disorders are unique to each patient. As a result, the safest and most effective therapeutic approach often requires precision pharmacy: the use of compounded therapies that, unlike commercially manufactured medications, can be precisely adjusted to meet individual needs and modified as therapeutic requirements change. In this article, the manifestations of polycystic ovary syndrome are reviewed, several common concomitant conditions are discussed, therapeutic interventions are suggested, and compounded formulations are provided.

Related Keywords: Mike Riepl, RPh, polycystic ovary syndrome, chronic anovulation, hyperandrogenism, polycystic ovaries, obesity, menstrual dysfunction, insulin resistance, metformin, infertility, hypothalamic-pituitary-adrenal axis, HPA axis, emotional stress, sex hormones, formulations, calcium supplementation, magnesium supplementation, vitamin D3 supplementation, zinc supplementation, hyperinsulinemia, cortisol, dietary recommendations

Related Categories: FORMULATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
May/Jun 2019
Pg. 192-199

Equine Cushing’s Syndrome
Vail Jane
Jan/Feb 2003
Pg. 27-29

Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce
, Gogola Margaret
Jul/Aug 2015
Pg. 289-293

Infertility Care and the Role of the Compounding Pharmacist
Filicpzuk Janina
Mar/Apr 2001
Pg. 136-139

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M
, Collin Michael
May/Jun 2016
Pg. 197-201

Wilson's Syndrome and T3 Therapy
Milner Martin
Sep/Oct 1999
Pg. 344-348

Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vail Jane
May/Jun 2007
Pg. 187-192

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J
, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Mar/Apr 2018
Pg. 172-175

Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George
, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010
Pg. 40-45

Feline Urologic Syndrome and Diet Formulation
Long Scott F
Sep/Oct 1999
Pg. 366-367

Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Tan Robert S
Jul/Aug 2005
Pg. 259-264

View Sample
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera
, Thompson Tara
Sep/Oct 2022
Pg. 378-384

Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
May/Jun 2012
Pg. 196-205

Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Cho Sung Kyung
, Ashworth Lisa Diggs, Goldman Shauna
Sep/Oct 2020
Pg. 367-369

Clinical Management and Review of Sjogren's Syndrome
Dyke Shannon
Sep/Oct 2000
Pg. 338

Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Horace Alexis E
, Akbarian-Tefagh Jessica
Nov/Dec 2013
Pg. 446-450

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill
, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014
Pg. 370-377

Compounding Metformin for Use in Functional Medicine
Desai Sarina
, Thompson Tara
Sep/Oct 2023
Pg. 362-366

Return to Top